The POST-ACS Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.
Also called NCT05322200
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 140 participants
- Sponsor
- Swansea Bay University Health Board
- Registry
-
NCT05322200
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT05322200. Randomized; triple masking; primary purpose treatment. Start 2022-08-31 (actual); primary completion 2024-04-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The POST-ACS Study
- Condition
- Diabetes Mellitus
- Condition
- Acute Coronary Syndrome
- Condition
- Coronary Artery Disease
- Intervention (Radiation)
- A computerized tomography (CT) coronary angiogram
- Intervention (Procedure)
- Vicorder (Skidmore medical, UK)
- Intervention (Other)
- Blood tests for inflammation and oxidative stress markers
- Lead sponsor
- Swansea Bay University Health Board
Record details
- Record id
cardio:ct-nct05322200- Content hash
595094a2ec7bb05090f100494015ddb39bb4198fe6e4c86c6c736d7afd2b0ecd